These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 2062676

  • 1. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML, Bihl H, Heinze HG.
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [Abstract] [Full Text] [Related]

  • 2. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J.
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E, Fagioli G, Mancini AF, Rosito P, Galli A, Alvisi P.
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [Abstract] [Full Text] [Related]

  • 4. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL, Shapiro B, Hutchinson RJ.
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [Abstract] [Full Text] [Related]

  • 5. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F, Stimamiglio P, Bertolazzi L, Cabria M, Conte M, Villavecchia GP, Garaventa A, Lanino E, De Bernardi B, Scopinaro G.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.
    Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD.
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [Abstract] [Full Text] [Related]

  • 7. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL, Shen SW, Sisson JC, Shapiro B.
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [Abstract] [Full Text] [Related]

  • 8. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S, Bandopadhayaya GP, Malhotra A, Agarwal S, Kumar R, Dhanapathi H.
    J Postgrad Med; 2004 Mar; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [Abstract] [Full Text] [Related]

  • 9. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T.
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [Abstract] [Full Text] [Related]

  • 10. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
    Garty I, Friedman A, Sandler MP, Kedar A.
    Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
    [Abstract] [Full Text] [Related]

  • 11. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
    Hausegger KA, Fueger GF, Ebner F, Urban C.
    Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
    Parisi MT, Greene MK, Dykes TM, Moraldo TV, Sandler ED, Hattner RS.
    Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
    [Abstract] [Full Text] [Related]

  • 13. [131I-MIBG scintigraphy for the detection of metastatic lesions from malignant pheochromocytoma--comparison of 131I-MIBG scintigraphy with 99mTc-MDP bone scintigraphy in detecting bone metastases].
    Ozawa N, Imaeda T, Seki M, Koike S.
    Kaku Igaku; 1988 Jan; 25(1):97-103. PubMed ID: 3373813
    [No Abstract] [Full Text] [Related]

  • 14. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C.
    Bull Cancer; 1988 Jan; 75(1):97-106. PubMed ID: 3359060
    [Abstract] [Full Text] [Related]

  • 15. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
    Bouvier JF, Philip T, Chauvot P, Brunat Mentigny M, Ducrettet F, Maïassi N, Lahneche BE.
    Prog Clin Biol Res; 1988 Jan; 271():707-20. PubMed ID: 3261425
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL, Lebtahi NE, Delaloye AB, Laurini R, Beck D.
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [Abstract] [Full Text] [Related]

  • 17. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S, Todo S, Imashuku S, Miyazaki T.
    Pediatr Radiol; 1987 Apr; 17(4):308-13. PubMed ID: 3601463
    [Abstract] [Full Text] [Related]

  • 18. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
    Giammarile F, Olier AL, Lumbroso J.
    Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
    [Abstract] [Full Text] [Related]

  • 19. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
    Geatti O, Shapiro B, Sisson JC, Hutchinson RJ, Mallette S, Eyre P, Beierwaltes WH.
    J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ, Büchler Frederiksen P, Kamper J, Jeppesen P.
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.